Senseonics Holdings, Inc. - Common Stock (SENS)
7.7800
+0.0500 (0.65%)
NASDAQ· Last Trade: Aug 14th, 1:18 PM EDT
Detailed Quote
| Previous Close | 7.730 |
|---|---|
| Open | 7.740 |
| Bid | 7.760 |
| Ask | 7.800 |
| Day's Range | 7.600 - 7.940 |
| 52 Week Range | 4.790 - 8.750 |
| Volume | 198,586 |
| Market Cap | 6.34B |
| PE Ratio (TTM) | -8.277 |
| EPS (TTM) | -0.9 |
| Dividend & Yield | N/A (N/A) |
| 1 Month Average Volume | 647,096 |
Chart
News & Press Releases
Cramer recommends buying Carpenter Technology (NYSE: CRS) and calls DXC Technology (NYSE: DXC) a value trap. Senseonics Holdings (NASDAQ: SENS) posts upbeat sales and Ubiquiti (NYSE: UI) reports worse-than-expected results. Hess Midstream (NYSE: HESM) is a winner while Zeta Global (NYSE: ZETA) announces a new CMO. UL Solutions (NYSE: ULS) is a potential buy and Coupang (NYSE: CPNG) is not recommended, but MercadoLibre (NASDAQ: MELI) and Amazon (NASDAQ: AMZN) are worth considering.
Via Benzinga · August 14, 2026
Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) raised its full-year 2026 revenue and gross-margin outlook after reporting second-quarter revenue growth of approximately 120% and its highest organic gross margin to date.
Net revenue for the second quarter totaled $14.5 million, compared with $
Via MarketBeat · August 7, 2026
Senseonics Holdings (NASDAQ:SENS) Jumps on Q2 Revenue Beat and Raised Full-Year Guidancechartmill.com
Via Chartmill · August 6, 2026
GERMANTOWN, Md., Aug. 06, 2026 (GLOBE NEWSWIRE) -- Senseonics Holdings, Inc. (NASDAQ: SENS), a medical technology company focused on the design, development and commercialization of long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes, today announced second quarter 2026 financial results and provided a business update.
By Senseonics Holdings, Inc. · Via GlobeNewswire · August 6, 2026